1. Volume 131, Issue 6, Pages 1674-1682 (December 2006)
A Randomized Trial of Rofecoxib for the Chemoprevention of Colorectal Adenomas 
John A. Baron, Robert S. Sandler, Robert S. Bresalier, Hui Quan, Robert Riddell, Angel Lanas, James A. Bolognese, Bettina Oxenius, Kevin Horgan, Susan Loftus, Dion G. Morton 
Gastroenterology 
Volume 131, Issue 6, Pages (December 2006)
DOI: /j.gastro
Copyright © 2006 AGA Institute Terms and Conditions

2. Figure 1
Enrollment, randomization, follow-up evaluation, and data analysis. The original study design included a rofecoxib 50-mg group; 25 patients were assigned to this treatment before it was decided not to proceed with this arm. ae, adverse event.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2006 AGA Institute Terms and Conditions